[Micropolycystic ovary syndrome: therapy of anovulation].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000858:Anovulation / Q000188:drug therapy*; D001971:Bromocriptine / Q000627:therapeutic use; D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D002996:Clomiphene / Q000627:therapeutic use; D003534:Cyproterone / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use; D006801:Humans; D010053:Ovary / Q000601:surgery; D010906:Pituitary Hormone-Releasing Hormones / Q000627:therapeutic use; D011085:Polycystic Ovary Syndrome / Q000517:prevention & control*
D000305:Adrenal Cortex Hormones; D006063:Chorionic Gonadotropin; D010906:Pituitary Hormone-Releasing Hormones; D002996:Clomiphene; D001971:Bromocriptine; D004997:Ethinyl Estradiol; D005640:Follicle Stimulating Hormone; D003534:Cyproterone
Sindrome dell'ovaio micropolicistico: la terapia dell'anovulatorietà.